Clive McCarthy

1.1k citations

29 papers · 673 indexed · h-index 16

Impact in

Physiology top 5%
- Adenosine and Purinergic Signaling
Organic Chemistry top 10%
- Asymmetric Synthesis and Catalysis
- Catalytic C–H Functionalization Methods
- Synthesis and biological activity

Papers in ⓘ

Molecular Biology 16
- Receptor Mechanisms and Signaling 5
- Chemical Synthesis and Analysis 4
- PI3K/AKT/mTOR signaling in cancer 3
Physiology 8
- Nitric Oxide and Endothelin Effects 5
- Adenosine and Purinergic Signaling 4

Co-authors: Keith Jones (4 shared papers)John M. D. Storey (2 shared papers)Martin Gosling (5 shared papers)Henry Danahay (4 shared papers)Peter Drueckes (3 shared papers)Andrew J. Clark (1 shared paper)Pascal Furet (4 shared papers)R. J. A. WALSH (5 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (9 papers)Journal of Cystic Fibrosis (3 papers)Journal of Medicinal Chemistry (3 papers)Cancer Research (3 papers)European Journal of Medicinal Chemistry (2 papers)
Partner nations: United Kingdom Switzerland United States

In The Last Decade

Clive McCarthy

28 papers receiving 632 citations

Peers

Countries citing papers authored by Clive McCarthy

Since Specialization

Citations

This map shows the geographic impact of Clive McCarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clive McCarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clive McCarthy more than expected).

Fields of papers citing papers by Clive McCarthy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clive McCarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clive McCarthy. The network helps show where Clive McCarthy may publish in the future.

Co-authors

The 25 scholars most cited alongside Clive McCarthy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Clive McCarthy Line = papers co-authored together Clive McCarthy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients Cancer Research ·Ralph Tiedt, Elisa Degenkolbe, Pascal Furet, B.A. Appleton, Sabrina Wagner, Joseph Schoepfer, Emily Buck, David A. Ruddy, John E. Monahan, Michael D. Jones, Jutta Blank, Dorothea Haasen, Peter Drueckes, Markus Wartmann, Clive McCarthy, William R. Sellers, Francesco Hofmann	2011	99
2	Potent small molecule inhibitors of spleen tyrosine kinase (Syk) Bioorganic & Medicinal Chemistry Letters ·Justine Lai, Paul J. Cox, Rajesh Patel, Shazia Sadiq, David Aldous, Sukanthini Thurairatnam, Keith Smith, Darren Wheeler, Savita Jagpal, Sofia Parveen, Gary Fenton, T. Harrison, Clive McCarthy, Paul Bamborough	2003	72
3	TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis American Journal of Respiratory and Critical Care Medicine ·Henry Danahay, Sarah Lilley, Roy Fox, Holly Charlton, Juan Sabater, Brian Button, Clive McCarthy, Stephen P. Collingwood, Martin Gosling	2020	65
4	Chiral induction in aryl radical cyclisations Tetrahedron Letters ·Keith Jones, Clive McCarthy	1989	56
5	Macrocyclic BACE-1 inhibitors acutely reduce Aβ in brain after po application Bioorganic & Medicinal Chemistry Letters ·Andreas Lerchner, Rainer Machauer, Claudia Betschart, Siem J. Veenstra, Heinrich Rueeger, Clive McCarthy, Marina Tintelnot‐Blomley, Anne-Lise Jaton, Sabine Rabe, Sandrine Desrayaud, Albert Enz, Matthias Staufenbiel, Paolo Paganetti, Jean‐Michel Rondeau, Ulf Neumann	2009	41
6	Adenosine receptor ligands as potential therapeutics in asthma. PubMed ·Fozard, Clive McCarthy	2002	34
7	Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors Bioorganic & Medicinal Chemistry Letters ·Carole Pissot‐Soldermann, Marc Gerspacher, Pascal Furet, Christoph Gaul, Philipp Holzer, Clive McCarthy, Thomas Radimerski, Catherine H. Régnier, Fabienne Baffert, Peter Drueckes, Gisele Tavares, Eric Vangrevelinghe, Francesca Blasco, Giorgio Ottaviani, Flavio Ossola, Julien Scesa, Janitha Reetz	2010	33
8	Aryl radical cyclisations: Quinoline, isoquinolone, and 1-benzazepin-2-onerings via 6- and 7-exo cyclisations Tetrahedron Letters ·Andrew J. Clark, Keith Jones, Clive McCarthy, John M. D. Storey	1991	33
9	Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Heinrich Rueeger, Jean‐Michel Rondeau, Clive McCarthy, Henrik Möbitz, Marina Tintelnot‐Blomley, Ulf Neumann, Sandrine Desrayaud	2011	32
10	Selective ET_AAntagonists. 5. Discovery and Structure−Activity Relationships of Phenoxyphenylacetic Acid Derivatives Journal of Medicinal Chemistry ·Peter C. Astles, Thomas J. Brown, Frank Halley, Caroline M. Handscombe, Neil V. Harris, Tahir Majid, Clive McCarthy, Iain M. McLay, Andrew Morley, Barry Porter, Alan G. Roach, Carol A. Sargent, Christopher Smith, R. J. A. WALSH	2000	32
11	A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential Bioorganic & Medicinal Chemistry Letters ·Neil J. Press, Roger Taylor, Joseph D. Fullerton, Pamela Tranter, Clive McCarthy, Thomas H. Keller, Lyndon Brown, Robert Cheung, Julie Christie, Sandra Haberthuer, Julia Hatto, Mark Keenan, Mark K. Mercer, Nicola E. Press, Nicola E. Press, Helene Sahri, Andrew R. Tuffnell, Morris Tweed, John R. Fozard	2005	25
12	A physical properties based approach for the exploration of a 4-hydroxybenzothiazolone series of β2-adrenoceptor agonists as inhaled long-acting bronchodilators Bioorganic & Medicinal Chemistry Letters ·David T. Beattie, Michelle Bradley, Andrew Brearley, Steven J. Charlton, Bernard Cuenoud, Robin A. Fairhurst, Peter Gedeck, Martin Gosling, Diana Janus, Darryl Jones, Christine A. Lewis, Clive McCarthy, Helen Oakman, Rowan Stringer, Roger Taylor, Andrew R. Tuffnell	2010	19
13	Tropomyosin receptor kinase inhibitors: a patent update 2009 – 2013 Expert Opinion on Therapeutic Patents ·Clive McCarthy, Edward R. Walker	2014	17
14	New non peptidic C5a receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Peter C. Astles, Thomas J. Brown, Paul Alan Cox, Frank Halley, Peter Lockey, Clive McCarthy, Iain M. McLay, Tahir Majid, Andrew Morley, Barry Porter, Andrew J. Ratcliffe, R. J. A. WALSH	1997	17
15	Selective Endothelin A Receptor Antagonists. 3. Discovery and Structure−Activity Relationships of a Series of 4-Phenoxybutanoic Acid Derivatives Journal of Medicinal Chemistry ·Peter C. Astles, Clive Brealey, Thomas J. Brown, Vincenzo Facchini, Caroline M. Handscombe, Neil V. Harris, Clive McCarthy, Iain M. McLay, Barry Porter, Alan G. Roach, Carol A. Sargent, Christopher Smith, R. J. A. WALSH	1998	16
16	An Efficient Synthesis of Nitroalkenes by Alkene Cross Metathesis: Facile Access to Small Ring Systems Organic Letters ·Graham P. Marsh, Philip J. Parsons, Clive McCarthy, Xavier G. Corniquet	2007	16
17	Selective Endothelin A Receptor Antagonists. 4. Discovery and Structure−Activity Relationships of Stilbene Acid and Alcohol Derivatives Journal of Medicinal Chemistry ·Peter C. Astles, Thomas J. Brown, Frank Halley, Caroline M. Handscombe, Neil V. Harris, Clive McCarthy, Iain M. McLay, Peter Lockey, Tahir Majid, Barry Porter, Alan G. Roach, Christopher Smith, R. J. A. WALSH	1998	12
18	Intramolecular alkyllithium additions to lactams; a synthesis of 2,3,9,9a-tetrahydro-1H-pyrrolo[1,2-a]indoles (pyrrolo[1,2-a]indolemnes) related to mitomycins Journal of the Chemical Society Chemical Communications ·John M. D. Storey, Clive McCarthy, Keith Jones	1991	10
19	Selective endothelin A receptor antagonists. 2. Discovery and structure-activity relationships of 5-ketopentanoic acid derivatives European Journal of Medicinal Chemistry ·Peter C. Astles, Thomas J. Brown, Neil V. Harris, Mark F. Harper, Clive McCarthy, Barry Porter, Christopher Smith, R. J. A. WALSH	1997	9
20	Indole alkaloid synthesis; a stereospecific preparation of functionalised cis-hexahydrocarbazoles Journal of the Chemical Society Chemical Communications ·Clive McCarthy, Keith Jones	1989	8

About Clive McCarthy

Clive McCarthy is a scholar working on Molecular Biology, Physiology, Organic Chemistry, Pulmonary and Respiratory Medicine and Oncology, having authored 29 papers that have together received 673 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (5 papers), Nitric Oxide and Endothelin Effects (5 papers), Adenosine and Purinergic Signaling (4 papers), Chemical Synthesis and Analysis (4 papers), Electron Spin Resonance Studies (4 papers), Cystic Fibrosis Research Advances (3 papers), Catalytic C–H Functionalization Methods (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Physiology (53 citations), Organic Chemistry (271 citations), Hepatology (43 citations), Toxicology (16 citations) and Computational Theory and Mathematics (64 citations). Clive McCarthy has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Keith Jones, John M. D. Storey, Martin Gosling, Henry Danahay, Peter Drueckes, Andrew J. Clark, Pascal Furet, R. J. A. WALSH, Sandrine Desrayaud and Thomas J. Brown. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Cystic Fibrosis, Journal of Medicinal Chemistry, Cancer Research and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact